Clinilabs employs a staff of more than 170 professionals dedicated to clinical research and client service. Our team includes physicians, nurse practitioners, physicians' assistants, psychologists, regulatory affairs professionals, project managers, clinical research associates, subject recruiters, laboratory technologists, laboratory assistants, data management staff, biostatisticians, medical writers, programmers, and quality assurance and compliance experts.
All of these individuals are supported by an experienced team of administrative personnel, and all work together to deliver high quality client service.
Gary K. Zammit, PhD
President and CEO |
Lorraine Marchand, MBA, MA
Chief Operating Officer |
Francis Wouters, DDS, PhD
Senior Vice President of
Business Development |
Yu Ding, MD
Vice President of Data Services
and IT |
Jon Freeman, PhD
Director of Laboratory Services |
Betsy A. Ellsworth, MSN, ANP
Director of Clinical Operations |
Elysa Feigenbaum
Director of Administration &
Human Resources |
Roxann Weirsky
Quality Assurance &
Compliance Manager |
Ronald Falcone, Jr.
Controller |
|
Gary Zammit, Ph.D. is the President and CEO of Clinilabs, Inc., a specialty contract research organization he founded in 2001. Prior to assuming his current position, Dr. Zammit served as President of Pharmasys International, a clinical drug development consulting firm he founded in 1995.
Dr. Zammit currently is a Clinical Associate Professor of Psychology (in Psychiatry) at the Columbia University College of Physicians and Surgeons. He earned a PhD degree in clinical psychology from the University of Toledo (Toledo, Ohio), where he won the Turin Service Award and the Leckie Scholar Award. Dr. Zammit completed an internship and fellowship in the Department of Psychiatry at the New York Hospital - Cornell University Medical College, where he won the Alumni Award for Excellence. Dr. Zammit is widely known as a key opinion leader in the field of clinical drug development, has authored more than 80 original reports and two books, and currently serves as an advisor to several pharmaceutical companies and non-profit organizations.
Ms. Marchand has more than 20 years experience in pharmaceutical drug development, and her track record includes the successful management and expansion of global clinical research business units. Ms. Marchand’s experience includes the development and management of global teams in both the public and private sectors of healthcare. She has led several initiatives resulting in reductions in drug development cycle time while at the same time reducing costs and process inefficiencies.
Previously, Ms. Marchand was Vice President of the Americas for Covance Inc, a drug development company and Executive Director of Global Development at Bristol-Myers Squibb Company. During her tenure at Porter Novelli, Ms. Marchand was Senior Vice President, Healthcare Marketing and Managing Director of Patients1st, a clinical trials recruitment business unit she developed. Previously, she was Director of The National Diabetes Education Program for the National Institutes of Health.
Ms. Marchand received a BS degree from the University of Maryland, and received the degree of MA in Journalism and Public Affairs at the American University, Washington, DC. She received Master of Business Administration degrees from the Columbia University Business School in New York City and the London Business School.
Dr. Wouters has extensive experience in contract research and clinical drug development, with over 20 years of operational and business development industry expertise in North America and Europe. At his most recent position at PharmaNet Development Group, Inc., a global drug development services company, he served as Vice President of Business Development, Strategic Initiatives, and Office Head. Dr. Wouters previously worked at MiniDoc, Inc., a company focused on electronic data capture in clinical trials, as Vice President of Sales and Marketing.
Dr. Wouters received his doctorate in Dental Surgery from the University of Paris, France, and a post-doctoral degree in Periodontology from the Karolinska Institute of Stockholm, Sweden. His background includes experience in neurology, pulmonology, cardiology, oncology, and periodontology.
Dr. Ding received the Doctor of Medicine degree from the Beijing Second Medical College (Beijing, China) and obtained advanced training as an Intern, Resident, and Chief Resident at the Beijing Shuili Hospital. Additionally, Dr. Ding went on to hold the positions of Attending Physician in the Department of Medicine and Deputy Chief in the Department of Respiration, Laboratory of Sleep and Respiration at the Beijing Shuili Hospital.
Dr. Ding has worked in the field of sleep technology at the Sleep Disorders Institute and the Mount Sinai School of Medicine in Manhattan. Dr. Ding is responsible for the management of clinical and clinical trial sleep laboratory data. Dr. Ding has developed special expertise in electronic data management, including CNS test data collected in multi-center clinical trials, serving more than 150 sites in the United States and abroad.
Jon Freeman, Ph.D. received his doctorate from the New School for Social Research, Graduate Faculty (New York), his MA from New York University, Graduate School of Arts and Science and completed a Sleep Medicine Fellowship at the North Shore University Hospital/Long Island Jewish Medical Center. Dr. Freeman is currently a licensed Clinical Psychologist in the state of New York and serves on the Clinical Faculty for the Sleep Medicine Fellowship at the Sleep Disorders Institute. Dr. Freeman has worked in the field of Sleep Disorders Medicine for over 20 years and earned his board registration as a Polysomnographic Technologist (RPSGT) in 1996.
Past and current research interests involve neurobiological predictors of affective and cognitive symptomatology in sleep-disordered subjects, power spectral analysis of the human EEG, and digital signal processing. Dr. Freeman has served as a primary consultant for small biotech and mid-sized and top 10 pharmaceutical companies helping them to develop QEEG biomarkers models for their compounds. He has served as a primary-and sub-investigator on over 25 clinical trials related to CNS development and has authored and co-authored more than a dozen publications in these areas.
As Director of Laboratory Services, Dr. Freeman oversees the collection and quality of all neurophysiologic signals captured as part of clinical trials research (phase I – IV). In addition, Dr. Freeman oversees the collection of all Neuropsychological and Psychometric assessments that are collected as part of clinical trials research and is responsible for training staff in the administration, collection and interpretation of these measures.
Ms. Ellsworth received the Degree of Master in Science in Nursing from Columbia University (New York), and is licensed and board certified as an Adult Nurse Practitioner. Ms. Ellsworth’s experience includes work in a variety of primary and critical care settings. As Director of Clinical Operations, Ms. Ellsworth is responsible for managing the clinical research activities of the clinical trials division, including the evaluation and monitoring of clinical trials subjects and the supervision and training of site staff. Since joining the staff of Clinilabs, Ms. Ellsworth has been a subinvestigator in over 70 clinical trials in the areas of sleep disorders, depression and Alzheimer’s disease.
Ms. Feigenbaum received her Bachelor of Arts degree in psychology from the State University of New York at Stony Brook. As Director of Administration and Human Resources, Ms. Feigenbaum guides and manages the overall provision of Human Resources services, policies, programs for the entire Company, manages the administrative office and all functions related to the business management of the organization. Ms. Feigenbaum has been a part of the Clinilabs team since it’s inception in February 2001.
Ms. Weirsky joined the Company in July 2007, with over ten years of experience in the Pharmaceutical/CRO industry. Her experience in therapeutic areas include oncology, cardiovascular, neurological, central nervous system, rheumatology, endocrine, analgesia, injection devices, and diagnostics. As Quality Assurance & Compliance Manager, Ms. Weirsky oversees the Company’s Document Management System and the implementation, and maintenance of Quality Systems for documentation, auditing, observations, corrective actions, product complaints, and training. Ms. Weirsky also provides leadership and oversight for development of document control system and writes, reviews, and approves policies and SOPs to ensure they meet quality standards. Additionally, Ms. Weirsky conducts and oversees internal and external audits as well as hosting and tracking sponsors audits.
Mr. Falcone holds a Bachelor of Arts degree from William Paterson University and has more than 24 years of experience in accounting and finance, in both the public and private sectors. Mr. Falcone joined Clinilabs in 2007. His experience includes position as the Corporate Controller of Tutogen Medical, a public medical device manufacturer, and Accounting Manager at Immunomedics, a public biotechnology company. Mr. Falcone has 21 years of management experience in a variety of industries, where he has been responsible for managing accounting, financial reporting, human resources, and information technology. Organizations that have benefited the most from Mr. Falcone’s experience have been those that are in a growth period.
|
